Literature DB >> 16134385

[The role of Salmonella and Yersinia in the pathogenesis of spondyloarthropathies and rheumatoid arthritis. I. Detection of bacteria, bacterial DNA, lipopolysaccharide and ECA antigen in synovial fluid or blood].

Waldemar Rastawicki1, Marek Jagielski, Rafał Gierczyński, Halina Garwolińska, Brygida Kwiatkowska, Anna Filipowicz-Sosnowska.   

Abstract

To investigate the role of Salmonella and Yersinia in the pathogenesis of spondyloarthropathies and rheumatoid arthritis synovial specimens from 92 patients were analysed for the presence of bacterial DNA with the use of polymerase chain reaction and for the presence of lipopolysaccharide and enterobacterial common antigen (ECA) with the use of Dot-ELISA. In addition, peripheral blood samples were available for PCR analysis from 68 patients. Salmonella and Yersinia chromosomal DNA was not found in any of the synovial specimens and blood samples from the patients. All of the synovial fluids were also culture-negative. Salmonella LPS antigens were observed in 8 (8.6%), Yersinia in 20 (21.7%) and ECA antigens in 32 (34.9%) synovial specimens. Our findings revealed the presence of bacterial degradation products, but not bacteria from the genus Salmonella and Yersinia or their DNA in the synovial fluid or blood of patients with spondyloarthropathies and rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16134385

Source DB:  PubMed          Journal:  Med Dosw Mikrobiol        ISSN: 0025-8601


  2 in total

1.  Correlation between Yersinia enterocolitica and type I collagen reactivity in patients with arthropathies.

Authors:  María G Lacoste; Héctor Tamashiro; Silvia G Correa; Ana M S de Guzmán; María S Di Genaro
Journal:  Rheumatol Int       Date:  2006-12-02       Impact factor: 3.580

2.  Antibodies Recognizing Yersinia enterocolitica Lipopolysaccharides of Various Chemotypes in Synovial Fluids From Patients With Juvenile Idiopathic Arthritis.

Authors:  Katarzyna Kasperkiewicz; Anna S Świerzko; Mateusz Michalski; Łukasz Eppa; Mikael Skurnik; Zbigniew Żuber; Maciej Cedzyński
Journal:  J Immunol Res       Date:  2022-09-21       Impact factor: 4.493

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.